66
Participants
Start Date
October 24, 2017
Primary Completion Date
September 30, 2024
Study Completion Date
March 31, 2025
Milrinone
The study intervention is an intravenous infusion of milrinone or placebo
Placebo (5% Dextrose)
The study intervention is an intravenous infusion of milrinone or placebo
Columbia University, New York
University of Rochester, Rochester
University of Pennsylvania, Philadelphia
RTI International, Durham
Duke University, Durham
Emory University, Atlanta
University of Alabama at Birmingham, Birmingham
Research Institute at Nationwide Children's Hospital, Columbus
Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland
Cincinnati Children's Medical Center, Cincinnati
University of Iowa, Iowa City
Children's Hospital of Wisconsin, Milwaukee
Children's Mercy, Kansas City
University of Texas Southwestern Medical Center at Dallas, Dallas
University of Texas Health Science Center at Houston, Houston
University of Utah, Salt Lake City
University of New Mexico, Albuquerque
Stanford University, Palo Alto
Brown University, Women & Infants Hospital of Rhode Island, Providence
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
NICHD Neonatal Research Network
NETWORK